Clopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover)

Sanofi-Aventis Groupe,54 rue La Boétie,F-75008 Paris,France🇪🇺 European Union

EMA Page

Authorised Date: Mar 14, 2010
Approval ID: c7dec55078d41a8b
Products: 1 listed
Opinion Adopted: N/A

Overview Summary

This document is a summary of the European Public Assessment Report (EPAR) for Clopidogrel/Acetylsalicylic acid Zentiva. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Clopidogrel/Acetylsalicylic acid Zentiva.

Therapeutic & Classification

Therapeutic Indication

### Therapeutic indication - Acute Coronary Syndrome - Myocardial Infarction

Therapeutic Area (MeSH)

N/A

ATC Code

B01AC30

ATC Item

combinations

Pharmacotherapeutic Group

Antithrombotic agents

Active Substances

Active Substance (Summary)

N/A

INN / Common Names

N/A

Active Substance Details

Substance	CAS	Monograph
clopidogrel	N/A	氯吡格雷
acetylsalicylic acid	N/A	阿司匹林

Quick Info

Approval IDc7dec55078d41a8b

Product NumberN/A

StatusAuthorised

Authorised DateMar 14, 2010

Opinion AdoptedN/A

Revision #N/A

Names & Aliases

EMA Name

Clopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover)

Medicine Name

Clopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover)

Aliases

N/A

Regulatory Flags

Orphan medicineUnknown

Generic medicineUnknown

BiosimilarUnknown

Conditional approvalUnknown

Exceptional circumstancesUnknown

Accelerated assessmentUnknown

Additional monitoringUnknown

Advanced therapyUnknown

Source Links

EMA Source

No risk management plan link.

Back to EMA Approvals